PREMIER HEALTH OF AMERICA IN (PHA.CA) Stock Analyst Ratings
Canada - TSX Venture Exchange - TSX-V:PHA - CA74052G1063 - Common Stock
0.025 CAD
+0.01 (+25%)
ChartMill assigns a Buy % Consensus number of 40% to PHA.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 0.2. This target is 716% above the current price.
PHA.CA was analyzed by 8 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about PHA.CA.
In the previous month the buy percentage consensus was at a similar level.
PHA.CA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-05-20 | Acumen Capital | Downgrade | Buy |
| 2021-08-30 | Acumen Capital | Downgrade | Buy |
PREMIER HEALTH OF AMERICA IN / PHA.CA FAQ
What is the price target for PHA stock?
8 analysts have analysed PHA.CA and the average price target is 0.2 CAD. This implies a price increase of 716% is expected in the next year compared to the current price of 0.025.
Can you provide the consensus rating for PREMIER HEALTH OF AMERICA IN stock?
The consensus rating for PREMIER HEALTH OF AMERICA IN (PHA.CA) is 40 / 100 . This indicates that analysts generally have a neutral outlook on the stock.